Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Michael Y. Choi(University of California San Diego), George F. Widhopf(University of California San Diego), Emanuela M. Ghia(University of California San Diego), Reilly L. Kidwell(University of California San Diego), Md Kamrul Hasan(University of California San Diego), Jian Yu(University of California San Diego), Laura Z. Rassenti(University of California San Diego), Liguang Chen(University of California San Diego), Yun Chen(University of California San Diego), Emily Pittman(University of California San Diego), Minya Pu(University of California San Diego), Karen Messer(University of California San Diego), Charles Prussak(University of California San Diego), Januario E. Castro(University of California San Diego), Catriona Jamieson(University of California San Diego), Thomas J. Kipps(University of California San Diego)
Cited by 186Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis